These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 24418861)

  • 41. Undifferentiated sarcoma: does it exist? A clinicopathologic study of 7 pediatric cases and review of literature.
    Alaggio R; Bisogno G; Rosato A; Ninfo V; Coffin CM
    Hum Pathol; 2009 Nov; 40(11):1600-10. PubMed ID: 19647855
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mixed embryonal/alveolar rhabdomyosarcoma of the prostate: report of a case with molecular genetic studies and literature review.
    Treetipsatit J; Kittikowit W; Zielenska M; Chaipipat M; Thorner PS; Shuangshoti S
    Pediatr Dev Pathol; 2009; 12(5):383-9. PubMed ID: 19175284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee.
    Butel T; Karanian M; Pierron G; Orbach D; Ranchere D; Cozic N; Galmiche L; Coulomb A; Corradini N; Lacour B; Proust S; Guerin F; Boutroux H; Rome A; Mansuy L; Vérité C; Defachelles AS; Tirode F; Minard-Colin V
    Cancer Med; 2020 Apr; 9(8):2698-2709. PubMed ID: 32087612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children's Oncology Group experience.
    Morotti RA; Nicol KK; Parham DM; Teot LA; Moore J; Hayes J; Meyer W; Qualman SJ;
    Am J Surg Pathol; 2006 Aug; 30(8):962-8. PubMed ID: 16861966
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myogenic markers in the evaluation of embryonal botryoid rhabdomyosarcoma of the female genital tract.
    Riedlinger WF; Kozakewich HP; Vargas SO
    Pediatr Dev Pathol; 2005; 8(3):355-61. PubMed ID: 16010486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytogenetic abnormalities in 42 rhabdomyosarcoma: a United Kingdom Cancer Cytogenetics Group Study.
    Gordon T; McManus A; Anderson J; Min T; Swansbury J; Pritchard-Jones K; Shipley J; ;
    Med Pediatr Oncol; 2001 Feb; 36(2):259-67. PubMed ID: 11452933
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunohistochemical analysis of a muscle ankyrin-repeat protein, Arpp, in paraffin-embedded tumors: evaluation of Arpp as a tumor marker for rhabdomyosarcoma.
    Ishiguro N; Motoi T; Osaki M; Araki N; Minamizaki T; Moriyama M; Ito H; Yoshida H
    Hum Pathol; 2005 Jun; 36(6):620-5. PubMed ID: 16021567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers.
    Furlong MA; Mentzel T; Fanburg-Smith JC
    Mod Pathol; 2001 Jun; 14(6):595-603. PubMed ID: 11406662
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myogenin and desmin immunohistochemistry in the assessment of post-chemotherapy genitourinary embryonal rhabdomyosarcoma: prognostic and management implications.
    Godbole P; Outram A; Wilcox DT; Duffy PG; Sebire NJ
    J Urol; 2006 Oct; 176(4 Pt 2):1751-4. PubMed ID: 16945640
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rhabdomyosarcoma of the breast: a clinicopathologic study and review of the literature.
    Li DL; Zhou RJ; Yang WT; Wang J; Yao XH; Cheng YF; Shi DR
    Chin Med J (Engl); 2012 Jul; 125(14):2618-22. PubMed ID: 22882949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic implications of anaplastic lymphoma kinase gene aberrations in rhabdomyosarcoma; an immunohistochemical and fluorescence in situ hybridisation study.
    Lee JS; Lim SM; Rha SY; Roh JK; Cho YJ; Shin KH; Yang WI; Kim SH; Kim HS
    J Clin Pathol; 2014 Jan; 67(1):33-9. PubMed ID: 23922356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proximal-type epithelioid sarcoma: a clinicopathologic study of 20 cases.
    Hasegawa T; Matsuno Y; Shimoda T; Umeda T; Yokoyama R; Hirohashi S
    Mod Pathol; 2001 Jul; 14(7):655-63. PubMed ID: 11454997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anaplastic lymphoma kinase aberrations in rhabdomyosarcoma: clinical and prognostic implications.
    van Gaal JC; Flucke UE; Roeffen MH; de Bont ES; Sleijfer S; Mavinkurve-Groothuis AM; Suurmeijer AJ; van der Graaf WT; Versleijen-Jonkers YM
    J Clin Oncol; 2012 Jan; 30(3):308-15. PubMed ID: 22184391
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Sclerosing rhabdomyosarcoma: a clinicopathologic study of four cases with review of literature].
    Zhu L; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):587-91. PubMed ID: 18070445
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma.
    Karanian M; Pissaloux D; Gomez-Brouchet A; Chevenet C; Le Loarer F; Fernandez C; Minard V; Corradini N; Castex MP; Duc-Gallet A; Blay JY; Tirode F
    Am J Surg Pathol; 2020 May; 44(5):607-616. PubMed ID: 32187044
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytogenetic and real-time quantitative reverse-transcriptase polymerase chain reaction analyses in pleomorphic rhabdomyosarcoma.
    Li G; Ogose A; Kawashima H; Umezu H; Hotta T; Tohyama T; Ariizumi T; Endo N
    Cancer Genet Cytogenet; 2009 Jul; 192(1):1-9. PubMed ID: 19480930
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Rhabdomyosarcoma and extraosseous Ewing's sarcoma].
    Harms D; Leuschner I; Krams M; Pilgrim TB; Treuner J
    Verh Dtsch Ges Pathol; 1998; 82():83-98. PubMed ID: 10095421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group.
    Davicioni E; Anderson MJ; Finckenstein FG; Lynch JC; Qualman SJ; Shimada H; Schofield DE; Buckley JD; Meyer WH; Sorensen PH; Triche TJ
    Am J Pathol; 2009 Feb; 174(2):550-64. PubMed ID: 19147825
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma.
    Hanna JA; Garcia MR; Go JC; Finkelstein D; Kodali K; Pagala V; Wang X; Peng J; Hatley ME
    Cell Death Dis; 2016 Jun; 7(6):e2256. PubMed ID: 27277678
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma.
    Ragazzini P; Gamberi G; Pazzaglia L; Serra M; Magagnoli G; Ponticelli F; Ferrari C; Ghinelli C; Alberghini M; Bertoni F; Picci P; Benassi MS
    Histol Histopathol; 2004 Apr; 19(2):401-11. PubMed ID: 15024701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.